A non-invasive measurement of skin autofluorescence as a marker of advanced glycation end products accumulation in chronic renal disease patients
碩士 === 中原大學 === 生物醫學工程研究所 === 104 === The accumulation of advanced glycation end products (AGEs) is thought to play a role in the pathogenesis of chronic complications of diabetes mellitus (DM) and renal failure. Cardiovascular diseases are the predominant causes of death in patients with end-stage...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2016
|
Online Access: | http://ndltd.ncl.edu.tw/handle/8atd3j |
Summary: | 碩士 === 中原大學 === 生物醫學工程研究所 === 104 === The accumulation of advanced glycation end products (AGEs) is thought to
play a role in the pathogenesis of chronic complications of diabetes mellitus (DM)
and renal failure. Cardiovascular diseases are the predominant causes of death in
patients with end-stage renal disease undergoing hemodialysis. Skin
autofluorescence (Skin AF) measurement is a non-invasive method for assessing
accumulation of tissue AGEs. The aim of this study is to establish the reference
curve of Skin AF for the Taiwan population and use the clinical data to determine
the factors affecting the AGEs accumulation in chronic renal disease patients. 50
healthy subjects and 92 hemodialysis patients with chronic renal disease were
enrolled in this study. The AGE Reader was employed to measure Skin AF and
all the blood routine examination were recorded. The resultant mean values of
Skin AF in healthy subjects are 1.35 ± 0.07 AU in 20-29 years; 1.88 ± 0.22 AU
in 30-39 years; 2.02 ± 0.27 AU in 40-49 years; 2.22 ± 0.31 AU in 50-59
years; 2.38 ± 0.37 AU in 60-69 years; 2.99 ± 0.65 AU in 70-79 years; 3.60 ±
0.96 AU in 80-89 years. It depicts that the age is an important factor affecting the
Skin AF. In the same age group the yellow race has higher level of Skin AF than
the Caucasian. It shows that the Skin AF measurement is affected by skin color.
It also results show that glycation levels is the strongest factor affecting the
accumulation of AGEs in the chronic renal disease subjects (include with DM and
without DM groups), and then dialysis duration, albumin and triglyceride.
|
---|